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 Psilocybin is a medicine that has shown the potential to deeply change the treatment of 
depression and anxiety (Daniel and Haberman) (Johns Hopkins). However, psilocybin is not 
merely a medical issue but a social and political one as well. In the 1960s, public fear about the 
effects of psilocybin resulted in severe legal restrictions on its use, even for medical research 
(Pollan 217). Today, many psilocybin advocates hope that it will avoid that fate (Haberman). 
Measuring public sentiment therefore seems crucial for this community to navigate the social 
and legal landscape.  
 Some studies have examined newspaper coverage to help gauge public sentiment about 
other psychoactive compounds (McGinty et al.) (Zhang et al.), but there seems to be no similar 
published work yet on psilocybin. Building on these previous studies, I read and hand-coded 
every article (a total of 534) mentioning psilocybin from four regional American newspapers 
between January 1, 1989 and December 31, 2019. Three main issues were examined: 1) Has 
sentiment about psilocybin changed? 2) Has the number of articles mentioning psilocybin 
changed? 3) Has there been a change in the use of different terms for psilocybin? 
 My hand-coded data seemed to indicate that sentiment in these four newspapers has 
fluctuated throughout the 30-year period, with a recent significant rise in positivity in only one 
newspaper. The number of articles mentioning psilocybin significantly increased in just one 
newspaper. The only term for psilocybin with a significant change in use was “hallucinogenic 
mushrooms,” which saw a decrease. These results could be a warning to psilocybin advocates 
about the risk of negative social and political sentiment eventually growing again, though this is 
not conclusive. More investigation of this issue is recommended. 
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A Note on Technical Specifications 
 My capstone project is a research study presented via a website. I built the website with a 
self-modified version of the ResponsiveBlogily theme on a WordPress content management 
system consisting mostly of HTML, CSS, PHP, and JavaScript code. Data tables are accessible 
on the website through links that connect to a WordPress media library. 
 I coded most of the data visualizations on the website with Vega-Lite, which is a data-
visualization grammar using JSON syntax that is built on another data-visualization grammar 
called Vega. Both Vega-Lite and Vega were developed by the University of Washington 
Interactive Data Lab. Vega largely pulls from the D3.js library. D3.js, in turn, is built using 
JavaScript. Vega-Lite accesses the data tables from the capstone research through "raw" copies 
saved on a GitHub repository. 
 Each Vega-Lite data visualization on the website has a bubble in the upper righthand 
corner with three grey dots. Clicking on this bubble opens a menu of options for viewers to 







Introduction and Description of the Capstone Project 
Explain the impetus for the capstone 
 This capstone began four years ago with my parents. In 2016, I read about medical 
studies that New York University and Johns Hopkins Medicine had just published about the 
chemical compound psilocybin in the Journal of Psychopharmacology (Ross et al.) (Griffiths et 
al.). Many previous medical studies, in addition to a vast body of anecdotal evidence, had 
reported that psilocybin contained the potential to help alleviate depression and anxiety (Grob et 
al.). In addition, some of those studies and anecdotes had found that people who took psilocybin 
often reported profound insights into their own mental states, as well as spiritual experiences that 
made them feel more connected to the world and people around them (Martin and Hevesi).  
 The studies at New York University and Johns Hopkins Medicine sought to explore these 
potential effects on patients with late-stage terminal cancer. I thought the results of these studies 
were remarkable. They found that a single dose of psilocybin, given in a calm and controlled 
setting with a licensed therapist, had an enormous impact on most of the study's participants. 
Most of the patients reported significantly reduced depression and anxiety concerning their 
impending deaths, which were only months away for many of them. Even beyond alleviation of 
the symptoms of depression and anxiety, many of the patients reported that the experience had 
been one of the most important of their entire lives.  
 I wondered if psilocybin would be able to help my mother, who had recently been 
diagnosed with lung cancer. She wasn't interested when I raised the possibility with her, but the 
idea lingered in my memory. My father had suffered a massive stroke several years earlier, 
becoming paralyzed and suffering from severe depression and anxiety, so I also considered if he 





 Unfortunately, psilocybin can be difficult to acquire. Unless you are part of a federally 
approved study, the mere possession of psilocybin is illegal almost everywhere in the United 
States (as well as much of the rest of the world). This illegality was one of the main reasons why 
my mother was too nervous to take psilocybin herself or offer it to my father as his caregiver. 
However, when my mother passed away, I became my father's primary caregiver. I offered him 
some small doses of psilocybin to see if they might help with the after-effects of his stroke. 
These doses were only moderately successful, but the occasional positive effects led me to 
continue reading about psilocybin research. 
 My interest in the therapeutic potential of psilocybin eventually led me to a group of 
people on the website Meetup.com. These people regularly met to discuss psilocybin and other 
chemical compounds loosely gathered under the name "psychedelics." At one of their meetings, 
a doctor gave a lecture about his research into the psychedelic ketamine. Ketamine can be legally 
prescribed as a painkiller in the United States and this doctor had often prescribed ketamine for 
pain. He had begun to notice that his patients who received ketamine sometimes also showed 
reduced depression and anxiety. He had started studying the psychiatric potential of ketamine 
and had become so optimistic about its possibilities that he had opened a clinic to provide 
ketamine therapy. 
 After hearing this lecture, I thought that perhaps ketamine therapy could help my father. I 
found a ketamine clinic near my father's home and began taking him there for sessions. The 
results were often extraordinary. For about a month, he showed noticeably less depression and 
anxiety. He also reported less pain. In addition, he regained some of his ability to move his 





first month. However, the results that I saw during that first month of treatment made me think 
that ketamine might eventually develop into a widely used therapy. 
 These experiences with my father and ketamine led me to consider if there was some way 
to create a capstone about ketamine therapy. My MALS course on "Digital Humanities" at the 
CUNY Graduate Center had shown me how data visualization methods could be used to find 
quantifiable information about mass media. Professors Matthew Gold and Stephen Brier taught 
me and my fellow students that we could critically examine texts wherever they occurred in 
society. During this class I often found myself running newspaper articles through data analysis 
software just for my own curiosity. Eventually, these experiments dovetailed with my interest in 
ketamine therapy and I wondered if I could examine how newspapers had been treating the 
growing use of ketamine therapy for psychological ailments. 
 There is a tremendous amount of positive thinking among psychedelic advocates that 
these chemical compounds will now avoid the stigma that they developed in the 1960s. That 
stigma led to many psychedelics, such as psilocybin, being so severely regulated that they could 
not be prescribed by doctors for any use. Yet I wondered whether this recent positivity was well-
founded. Although I shared much of the optimism of the psychedelic community, I thought there 
was little hard data about public attitudes toward these compounds. I began to wonder if I could 
contribute to psychedelic research by using an analysis of newspaper coverage of ketamine 
therapy as a window into that medicine's reputation among the general American public. 
 I spent several months conceptualizing the methods of data analysis and visualization that 
have been used in my submitted capstone. Unfortunately, relatively late in my preparations, I 
discovered that the research team of Zhang et al. had already published a study examining 





would be very difficult to do my capstone without copying major portions of their work. Thus, 
my mind returned to the medicine that had started me down this path in the first place with my 
parents – psilocybin. There did not seem to be any published studies on newspaper coverage of 
psilocybin. I decided to perform the research for my capstone very similarly to how I had 
planned with ketamine, but simply switch the focus to psilocybin. In this way, I was also able to 
use the study by Zhang et al. as an example that could help me flesh out the processes of my own 
research. Zhang et al. also pointed me in the direction of work by McGinty et al. that had studied 
newspaper coverage of opioids.  
 I felt that building a website would be the best way to present my research. A website 
would allow me to create data visualizations that could update themselves if I changed any of the 
data. In addition, a website would be more quickly accessible to the wider psilocybin research 
and advocacy community. 
 
Describe the aims of the capstone 
 My capstone research aimed to examine coverage of psilocybin in four regional 
American newspapers for the 30-year period from January 1, 1989 to December 31, 2019. I 
sought to answer three questions about newspaper coverage: 
 1) Has sentiment about psilocybin changed? 
 2) Has the number of articles mentioning psilocybin changed? 
 3) Has there been a change in the use of different terms for psilocybin? 
 It should be stressed that these questions are only about newspaper coverage, not general 
public sentiment about psilocybin. However, I felt that examining newspaper coverage similarly 
to Zhang et al. and McGinty et al. could provide an initial step for psilocybin advocates to gain 





longer be a viable way to accurately gauge media opinion. This seemed especially true 
considering the growth of other media outlets such as cable news, podcasts, and YouTube 
channels. However, an analysis that took into account the myriad media sources of the modern 
era seemed far beyond the scope of a capstone project.  
 I wanted my study to be as rigorous as possible, so that members of the psilocybin 
community could truly benefit from my research. My hope was that my study would, in a small 
way at least, inform the actions of both psilocybin researchers and advocates. I also wanted my 
capstone to provide information to an audience beyond the psilocybin community. I wanted the 
information on the capstone website to be beneficial to anyone curious about psilocybin. To that 
end, I provided a concise but thorough explanation of both the science and social/political history 
of psilocybin in the United States. If I can contribute to anyone learning about psilocybin in more 
depth, even if they are not interested in the specific results of my study, then I will consider my 
capstone website to be a success. 
 







Theoretical Framing and/or Methodology Used 
Theoretical framing that informed the capstone 
 This capstone was a reaction to the tremendous optimism among many psilocybin 
researchers. As just a few examples of current psilocybin research (in addition to the studies 
already mentioned above from New York University and Johns Hopkins Medicine), a study at 
the University of California in Los Angeles has examined whether psilocybin can help the 
anxiety of patients facing end-stage cancer (Grob et al.). Another peer-reviewed study has 
examined the effects of psilocybin in the treatment of alcohol addiction (Bogenschutz et al.). 
Johns Hopkins Medicine is currently conducting many studies about psilocybin's potential, 
including its impact on depression, anorexia nervosa, nicotine addiction, and Alzheimer's 
Disease (Johns Hopkins).  
 Beyond the scientific community, my capstone is also a reaction to the community of 
psilocybin advocates who hope that it will generally gain a more respectable position in 
American life. A book about psychedelic research called How to Change Your Mind by 
journalist Michael Pollan was a #1 New York Times bestseller in 2018 ("Hardcover Nonfiction"). 
American companies now openly market psilocybin tours of Jamaica, where possession is legal 
(Leonhardt). Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies, 
has said: "We are not the counterculture, we are the culture" (Schwartz). Matthew Johnson et al. 
have written about psychedelic research that "science has the potential to facilitate innovative 
therapeutic breakthroughs by replacing fear and misinformation with scientifically based 
conclusions and facts" (166).  
 However, there was a similar level of optimism about the potential of psilocybin in the 





psilocybin becoming part of the regular fabric of American life. However, psilocybin and other 
psychedelic compounds soon escaped the rigorous clinical settings (sometimes with the help of 
researchers themselves, such as Timothy Leary). Psilocybin started being used by a wide swath 
of the public, particularly among teenagers and young adults. A social and political backlash 
developed, and the media became filled with lurid stories about the dangers of psychedelic 
compounds. In reaction to the fears of many Americans about the effects of psychedelics, the 
federal government classified psilocybin as a "Schedule 1" drug in 1970 (Johnson et al.). This 
meant that it had no approved medical use in the United States. Not only was it illegal to be 
taken recreationally, but not even a doctor could prescribe it. Psilocybin remains a Schedule 1 
drug to this day.  
 Therefore, it seems important for the current era's growing body of research and activism 
to be able to gauge the opinion of the American public about psilocybin. Without that gauge, it 
seems possible that a social and political backlash could develop once again, removing the 
chance for millions of Americans to potentially discover new relief from psychological ailments. 
A study to analyze newspaper coverage of psilocybin over the last 30 years seemed like it could 
help the psilocybin community in its quest for broader acceptance. 
 
Methodology in dialogue with other scholars 
 As I discovered, there is already a body of work that has examined newspaper coverage 
of psychoactive substances in order to help gauge the sentiment of the American public. In 
particular, my study received much of its inspiration from studies by Zhang et al. about ketamine 
therapy and McGinty et al. about prescription opioids. 





divided the United States into four geographical regions (Northeast, South, Midwest, and West) 
and chose one newspaper from each region. I followed the same format, choosing the New York 
Times (Northeast), Tampa Bay Times (South), St. Louis Post-Dispatch (Midwest), and San Diego 
Union-Tribune (West). Examining all of these newspapers in total could potentially mitigate 
regional differences in sentiment toward psilocybin. Some of these newspapers have absorbed 
other newspapers over the time period being examined (January 1, 1989 to December 31, 2019). 
Following the example of McGinty et al., the archives of those absorbed newspapers have been 
included under the titles of their current publishers. 
 I chose the four newspapers above because the online media database Nexis Uni (the 
academic research portal of the LexisNexis database) had archives of their articles over the time 
period being examined. Sets of articles were created by searching Nexis Uni for every article that 
mentioned psilocybin. McGinty et al. and Zhang et al. also used aggregated newspaper databases 
to compile their articles, as opposed to using the databases of the newspapers themselves 
(LexisNexis in the case of McGinty et al. and newspaperarchive.com in the case of Zhang et al.). 
In addition, I used Nexis Uni in order to avoid any variations in the quality of databases and 
search engines administered by the newspapers themselves. 
 McGinty et al. and Zhang et al. also helped me realize that I would need to have more 
than one category in which to judge the sentiment of individual newspaper articles. Both of these 
studies examined several ways in which articles could express sentiment, leading me to create 
five sentiment categories specific to psilocybin. 
 
Additional remarks on methodology 





terms in addition to "psilocybin." Although synthetic psilocybin is available, the compound is 
often ingested via the mushrooms which naturally contain it. Unlike many other psychoactive 
substances, psilocybin is therefore frequently referred to by its delivery container (mushrooms), 
even in journalistic contexts. After extensive reading of psilocybin journalism, the present study 
chose four search terms for psilocybin: "psilocybin," "magic mushrooms," "hallucinogenic 
mushrooms," and "psychedelic mushrooms." Searches were made for both plural and singular 
forms. If other common journalistic terms for psilocybin are discovered which are not 
represented in the present study, this could be a topic for future research. There are also many 
slang terms for psilocybin, such as "shrooms" or "boomers." However, most of these slang terms 
also have other meanings and seemed rarely used by the newspapers in this study unless other 
terms for psilocybin were also used. For example, a search for "shrooms" in the New York Times 
over the study's time period only found 5 articles using this term for psilocybin, but 25 non-
psilocybin uses. Therefore, I did not include these slang terms in my Nexis Uni searches. 
 There are also a small number of non-psilocybin mushroom species that have 
hallucinogenic compounds (such as muscimol, which is found in some Amanita species). There 
would therefore seem to be at least some risk that terms such as "hallucinogenic mushrooms" or 
"psychedelic mushrooms" might refer to these species rather than psilocybin species. For 
example, 4 out of 308 New York Times articles in the Nexis Uni search results referred to these 
mushrooms and had no references to psilocybin mushrooms. To avoid this problem, I removed 
articles from the Nexis Uni sets of each newspaper if they only referred to non-psilocybin 
mushrooms. 
 I removed duplicate articles from the sets, even if they had different date lines. Nexis Uni 





manual removal of duplicates was also necessary. However, multiple articles about the same 
news event were included as long as the articles seemed independently written (for example, 
following new developments in the event or approaching it from a different perspective). I 
counted the number of articles in which a term occurred, not each individual occurrence of a 
term. Some articles used more than one term, which is why the overall number of articles in each 
newspaper's set is lower than the number resulting from adding together the articles in each term 
category. It is also important to note that many of these articles do not have psilocybin as their 
central topic. Many journalistic mentions of psilocybin are made only as parts of articles about 
different topics. 
 After the searches and data cleaning described above, the final total article set consisted 
of 534 articles from all four newspapers. Of these, 304 articles were from the New York Times, 
89 articles were from the San Diego Union-Tribune, 67 articles were from the St. Louis Post-
Dispatch, and 74 articles were from the Tampa Bay Times. 
 Determining the sentiment of articles presented challenges. Nexis Uni, for example, has a 
feature called "Negative News" that uses algorithms to create a set of only negative articles for a 
particular search term. However, the Negative News results for psilocybin were often inaccurate. 
As just one example, the Negative News algorithms chose the New York Times article "Cancer 
Study of Hallucinogen Hints at New Role for Illegal Drug," (Hoffman) which described studies 
that showed psilocybin could help treat depression and anxiety. Yet an article describing patients 
using psilocybin to reduce mental illness would seem to be a positive article. I suspect that 
Negative News chose this article due to its frequent use of words that often have negative 
connotations such as "depression" and "anxiety." Many more examples of incorrect algorithmic 





 Even if attempts were made to adjust the negative weight of words in order to fit the 
paradigm of psilocybin, algorithms might still have difficulty with nuances. For example, in a 
New York Times review (Kakutani) of the book Prozac Nation, the word "depression" was used 
with the same definition as the positive article mentioned above, i.e. as a clinical psychological 
issue. However, in this context, "depression" was a negative word because the review implied 
that the author used psilocybin as a way to ineffectively escape her depression, not to treat it. 
 To avoid problems with using algorithms to determine the sentiment of articles, I decided 
that it was a better option for me to personally read and hand-code every article. Yet there were 
still significant risks with this option. For example, I was only a single researcher, which could 
result in significant bias about sentiment. Future studies in this area might be improved by 
having more than one researcher determine the sentiment of articles. The sentiment analyses of 
each researcher could then be compared and perhaps averaged. In addition, there is a risk that the 
same researcher could give different sentiment ratings to an article depending on the condition of 
their mind at a given moment. A full discussion of the debate between machine and human 
judgment is beyond the scope of the present study, touching on the fields of philosophy, 
computer science, and logic. 
 After settling on personally hand-coding every article, other challenges presented 
themselves. Take, for example, the New York Times article "Ideas Unlimited, Built to Order" 
(Schiesel). This article praised the pleasant effects that psilocybin could have for its users, which 
would seem to be positive, but the article also called psilocybin "toxic," which would seem to be 
negative. In addition, even articles that were clearly determined to be positive or negative might 
have had different degrees of positivity or negativity. For example, a brief article describing an 





negative impact from a longer article about a psilocybin arrest that also details the damaging 
impact of that arrest on the life of the accused. It would therefore seem negligent to treat these 
two articles identically. 
 To address these problems, I found inspiration in previous studies about media portrayals 
of psychoactive substances. McGinty et al. and Zhang et al. created different thematic categories 
in which each article could be assessed. Since their thematic categories were not exactly 
applicable to psilocybin, I identified five thematic categories to rate sentiment specifically about 
psilocybin. For each category, I personally gave every article a score of -1 (negative), 0 (neutral), 
or +1 (positive). I then calculated the total scores in each thematic category for each year for 
each newspaper. I also added together the scores in each category to provide a single sentiment 
score for each year. 
 I used five thematic categories as I classified the 534 articles in my study:  
 1) Legality: Is using psilocybin seen merely as a criminal act (negative) or only 
unfortunately illegal (positive)? 
 2) Mode of Action: Is psilocybin seen as physically damaging (negative) or physically 
beneficial (positive)?  
 3) Personal Impact: Is psilocybin seen as psychologically detrimental (negative) or 
psychologically beneficial (positive) to the user?  
 4) Scientific Integrity: Is psilocybin research considered pseudoscience (negative) or 
rigorous and serious (positive)?  
 5) Social Impact: Is psilocybin seen as detrimental (negative) or beneficial (positive) to 
society beyond the user? 





action concerns physical effects of psilocybin while personal impact concerns psychological 
effects. Returning to the example mentioned above ("Ideas Unlimited, Built to Order" [Schiesel]) 
I gave a +1 for personal benefit to the praise for psilocybin's pleasant psychological effects, but I 
gave a -1 for mode of action to the reference to psilocybin as "toxic." 
 
Website building and programming methodology 
 I presented my study and full capstone in a website built with the content management 
system WordPress and the WordPress theme ResponsiveBlogily. However, ResponsiveBlogily 
was not exactly suited for presenting a master's capstone, so I had to personally code substantial 
changes to the HTML and CSS. I hand-coded most of the website's data visualizations with a 
JSON grammar called Vega-Lite. I used GitHub to store the data tables that were accessed by the 
Vega-Lite data visualizations. Code other than HTML and CSS cannot be inserted directly into 
WordPress, so I needed to insert the Vega-Lite into the ResponsiveBlogily JavaScript files. The 
few data visualizations not coded in Vega-Lite were built with Tableau software, and the 
Tableau images were inserted directly into the WordPress text content. 
 
Other works in dialogue with this capstone 
 Despite the optimism that I presented above, there are some psilocybin advocates today 
who are worried about a social and political backlash similar to the 1960s. This group seems to 
think that this backlash might result from a major rise in recreational use of psilocybin and/or 
efforts to legalize its use without the guidance of trained therapists and doctors. In 2019, the 
journalist Michael Pollan, who strongly supports allowing regulated psilocybin use in controlled 





Denver's recent decriminalization of psilocybin. Pollan wrote: "Great enthusiasm has been 
inspired by psychedelic research, and I share it, but we should be mindful of psychedelic history 
too, in which exuberance about the potential of these medicines gave way to a political backlash 
that set back research, and access, for more than 30 years. It doesn’t have to happen again, but it 
could." Thomas Insel, the former head of the National Institute of Mental Health, told a 
conference of psychedelic researchers in 2017: "Don't screw this up… the danger of having 
someone have a really negative experience and not having put everything in place to be able to 
help them… can really poison the well here for everybody, so in this stage, early in chapter 1, 
let's be very mindful of risk" (MAPS). 
 The results of my study provide at least some support for the warnings of this sector of 
the psilocybin community. Of the four newspapers that I examined, positivity toward psilocybin 
only seemed to significantly rise in the New York Times. In addition, the total number of articles 
mentioning psilocybin also only significantly rose in the New York Times. In fact one of the other 
newspapers showed a significant downward trend in psilocybin mentions. 
 I believe that the tepidness of the other three newspapers toward psilocybin could mean 
that psilocybin advocates are still a small minority in the United States. Although my study is far 
from conclusive and much more research of this topic needs to done, I suspect that most of the 
American public remains unaware of the recent positive research about psilocybin.  
 Psilocybin can have powerful and destabilizing effects on its users. However, many 
psilocybin therapists seem to believe that with the right frame of mind, proper setting, and 
education, these destabilizing experiences can often be beneficial to users. Without these proper 
safety measures, though, psilocybin use has the potential to be very frightening, both to users and 





about these difficult experiences (also known as "bad trips") also might become widespread, 
which could precipitate a legal crackdown. 
  
How this capstone relates to my concentration and courses 
 My track in the MALS program has been in data visualization. Part of what this track is 
designed to teach is the creation of visual representations of quantitative data that are not only 
easy for viewers to understand but also compelling. In addition, MALS data visualization 
students should be able to use data visualizations to enhance understanding of the textual 
concepts and research being presented. 
 My study incorporated three formats of data visualization: heatmaps, line charts, and 
trend lines. Here are some examples of each visualization from my study: 
 Heatmaps 
 







 Line Charts 
 
Figure 17: Line chart showing yearly changes in terms used 
 Trend Lines 
 






 I also incorporated fMRI scans from a study by Carhart-Harris et al., which used  
visualizations of the human brain to explain data about changes in neural activity: 
 
Figure 1: fMRI scans showing psilocybin's effects on human brains 
 The MALS program first introduced me to the nuances of data visualization though the 
course "Data Visualization Methods" taught by Lev Manovich. From Manovich, I learned how 
to build precise visualizations with the software Excel and Tableau. Manovich also focused me 
on finding ways to make the visualizations compelling and noticeable (to "pop"). When building 
my capstone, I used Excel and Tableau to experiment with a wide array of visualizations for the 
data that I collected. After determining which visualizations worked best, I could then code them 
for the capstone website with Vega-Lite (a JSON grammar). 
 The next MALS course that influenced my capstone was "Digital Humanities" with 
Matthew Gold and Stephen Brier. Gold and Brier taught me how to use data analysis tools like 
Voyant and Palladio to examine text wherever I found it in society. They opened my mind to the 
possibilities of using text analysis to discover previously unknown facets of a culture. For one 
project, I performed text analysis of several Annual Reports from the Metropolitan Transit 
Authority. For another project, I created Palladio data visualizations to explain the development 
of works by the artist Henry Rollins. It was the combination of text analysis training from 





that allowed me to analyze and visualize the data that I collected about newspaper articles for my 
capstone. Gold and Brier also taught me to relentlessly critique my data analysis methods in an 
attempt to discover biases and try to mitigate them. Some of the impact of this teaching can be 
seen in my study's frequent reminders that the results are far from conclusive and that more 
research is highly recommended. 
 Another CUNY Graduate Center course that had a strong impact on my capstone was 
"Data Visualization" in the Computer Science department, taught by Ronak Etemadpour. This is 
the course that introduced me to Vega-Lite, which was the JSON grammar that I used to code the 
data visualizations in my capstone website. Etemadpour also gave me the opportunity to create  
websites to display the data visualizations that she assigned, combining my website coding 
knowledge of HTML, CSS, and JavaScript with data visualization code from D3.js, Python, and 
Vega-Lite. This allowed me to eventually build a website to present my capstone research in a 
format that was functional on both desktop and mobile devices for a variety of web browsers. 
 
Evaluation and Continuation 
Evaluation of the capstone 
 The results of my study surprised me. Having read a great deal about optimism in the 
psilocybin research and advocacy communities, I was inclined to believe that newspaper 
coverage of psilocybin would reflect this. However, the results of my study did not support my 
inclinations. Despite my own hope that psilocybin will someday be allowed a legal and open 
place in psychiatric therapy, my research has made me realize that this optimism might be 
premature. Now my hope is that my results will remind the psilocybin medical and advocacy 





unwittingly (or wittingly) help it become a recreational drug, as arguably happened in the 1960s, 
the results might be unfortunate. Millions of people could lose the chance to improve their 
mental well-being, a vast body of scientific research could be lost, and a tragic number of people 
could be imprisoned simply for wanting to become better human beings. 
 I faced a variety of setbacks during the creation and development of this capstone. For 
example, I originally wanted to create a capstone around ketamine therapy, which had helped my 
father deal with his post-stroke ailments. I engaged with a number of ketamine clinics about 
collaborating. My goal was to create research that combined textual analysis of their websites 
and patient materials with anonymized medical data that the clinics had collected about their 
patients. However, all of these attempts fell apart because of the clinics' understandable concerns 
about protecting the privacy of their patients. 
 After collaborations with ketamine clinics turned out to not be possible, I decided to 
focus on newspaper coverage of ketamine. I determined a time frame for articles to examine, 
developed hypotheses about how particular journalistic terms for ketamine might have changed 
in popularity, and began compiling some data sets. Then I discovered that Zhang et al. had 
already done much of this work in their own study. Their process was too similar for me to stake 
out original research with my capstone. After some initial worries, this problem was resolved 
when I realized that I could probably switch the focus of my research to psilocybin without 
losing much of the essence of my original ketamine focus. Discovering the work of Zhang et al. 
then turned out to be a blessing in disguise, because after reading their study and a similar study 
by McGinty et al., I realized that my original idea of examining only articles from the New York 





 Another large challenge came when I discovered that in order to create the multi-
dimensional data visualizations that I planned, the Vega-Lite grammar required CSV data tables 
to be arranged in a very non-standard way. This would require me to personally reconfigure 
every cell in my data tables to fit Vega-Lite's idiosyncratic method. I briefly considered 
completely abandoning Vega-Lite and instead using images of my data visualizations built with 
Tableau software. However, my desire to make my capstone website as dynamic as possible led 
me back to Vega-Lite, and so I resolved the problem by simply taking the time to personally 
reconfigure all of my data tables.  
 
Continuation of the capstone 
 I plan to continue working on my capstone project after submission for my master's 
degree. There are a number of areas in which it can be expanded and improved. For example, it 
was beyond the current scope to use political leanings when choosing newspapers (particularly 
since the political leaning of a newspaper can change dramatically over a 30-year period). If I 
could devise a rigorous method to include political leanings in an analysis of psilocybin 
coverage, the results might be more helpful. In addition, it could be revealing to research how 
psilocybin coverage will change in newspapers for regions where it has been decriminalized, 
such as Denver and Oakland. It might also be helpful to expand newspaper analysis to 
psychedelic compounds other than psilocybin. My study was partially inspired by a similar study 
about the psychedelic ketamine, and it might be helpful to the psychedelic community to gauge 
newspaper coverage of compounds such as lysergic acid diethylamide (LSD) and N,N-
dimethyltryptamine (DMT). I am also interested in expanding the parameters of this project 





cable news, YouTube channels, social media, and other sources. This was beyond the scope of 
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